HR2286-119

1. Short title This Act may be cited as the American Genetic Privacy Act of 2025.

2. Prohibition on disclosure of certain genetic information to People’s Republic of China No individual or entity may sell or offer for sale covered information, including aggregated covered information— to the People’s Republic of China; or to any entity under the influence, control, or ownership of the People’s Republic of China. No commercial DNA testing service may disclose, in any manner, covered information, including aggregated covered information— to the People’s Republic of China; or to any entity under the influence, control, or ownership of the People’s Republic of China. A violation of this section shall be treated as a violation of a regulation under section 18(a)(1)(B) of the Federal Trade Commission Act (15 U.S.C. 57a(a)(1)(B)) regarding unfair or deceptive acts or practices. The Federal Trade Commission shall enforce this section in the same manner, by the same means, and with the same jurisdiction, powers, and duties as though all applicable terms and provisions of the Federal Trade Commission Act (15 U.S.C. 41 et seq.) were incorporated into and made part of this section. Any person who violates this section shall be subject to the penalties and entitled to the privileges and immunities provided in the Federal Trade Commission Act. In this section: The term commercial DNA testing service means a person that provides genealogical or ancestry-related information based on an individual’s DNA. The term covered information means the genetic information of an individual that was originally acquired from such individual through the use, by such individual, of a commercial DNA testing service. The term genetic information means, with respect to any individual, information about such individual’s genetic tests. The term genetic test has the meaning given such term by section 201 of the Genetic Information Nondiscrimination Act of 2008 (Public Law 110–233; 42 U.S.C. 2000ff).